Build vs Buy Healthcare AI
By Alex Mastryukov · Last updated: October 4, 2026
A custom-development company telling you to build everything would be commercially convenient.
It would also be bad advice.
There are healthcare AI products I would never recommend rebuilding from zero unless you have a very specific reason.
The useful decision is not “custom is better” or “SaaS is cheaper.”
It is:
Where does your competitive or operational value actually live?
Buy when the problem is standard
If your need is common and a mature product fits the workflow, start by buying it.
Examples can include:
- straightforward transcription/scribing;
- generic meeting summarization;
- commodity OCR;
- standard cloud infrastructure;
- ordinary ticketing;
- common communication channels;
- standard analytics components;
- mature cybersecurity tooling.
Rebuilding commodity software gives you all the maintenance responsibility and none of the differentiation.
That is not innovation.
That is a hobby with a budget.
Build when the workflow is the product
Custom development becomes attractive when the difficult part is specific to your organization or business model.
For example:
- unusual EHR or legacy integration;
- proprietary clinical workflow;
- local payer logic;
- special patient-routing rules;
- multilingual workflow no standard product handles well;
- unique data model;
- unusual security/deployment requirement;
- AI behavior tightly connected to internal operations;
- a startup whose core IP is the workflow itself.
If forcing your process into the SaaS product requires 40 workarounds, the “cheap” product may become very expensive operationally.
The real cost of SaaS is not the subscription price
Suppose Product A costs $1,500 per month.
That number is easy to compare with a development proposal.
But include:
- implementation;
- integrations;
- staff time;
- migration;
- required process changes;
- extra modules;
- per-user or per-minute fees;
- vendor-specific consulting;
- limitations that leave manual work in place;
- switching cost later.
SaaS can still win comfortably.
Just compare total workflow cost, not the first line on the pricing page.
The real cost of custom software is not the first build
Custom development has the opposite accounting problem.
People budget for version one and forget:
- hosting;
- support;
- security updates;
- model/API cost;
- monitoring;
- bug fixes;
- vendor/API changes;
- new browser/device behavior;
- regulatory changes;
- staff requests;
- future integrations.
Owning the source code does not make maintenance disappear.
It merely makes the maintenance problem yours.
Integration often decides the question
A standalone product may be excellent and still create more work if staff has to copy information between it and the EHR.
Before buying, ask:
- Does it support our exact EHR/version?
- Read only, or write too?
- Which objects and workflows?
- Real-time or batch?
- Does it support our scheduling/billing/telephony stack?
- Who maintains the integration?
- What happens when the vendor API changes?
Sometimes one missing integration turns a brilliant AI product into another screen staff refuses to open.
Data and IP may decide the question for startups
If you are building a healthcare startup, ownership matters differently.
A clinic buying a scribe does not need to own the scribe’s source code.
A startup whose core product is a proprietary clinical reasoning workflow may care deeply about:
- source-code ownership;
- model portability;
- training/evaluation data;
- proprietary prompts/rules;
- customer-specific configuration;
- infrastructure ownership;
- clean IP assignment for investors.
The architecture should reflect what part of the system is actually company IP.
You can still use third-party models and infrastructure while owning the workflow layer.
Buy the commodity layer, build the differentiator
This is my preferred pattern most of the time.
For example, a custom medical workflow might use:
- commercial speech-to-text;
- commercial LLM APIs;
- managed cloud database;
- standard authentication;
- third-party messaging API;
while we build:
- clinic workflow;
- context model;
- integrations;
- business rules;
- evaluation suite;
- admin configuration;
- proprietary reasoning/application layer.
You do not need to train a foundation model to own valuable healthcare AI IP.
You need to own the part that makes the generic model useful in your specific problem.
Internal team vs external development
If you already have a strong internal product, engineering, security and healthcare integration team, they may be the right people to build it.
External specialists are useful when:
- the internal team lacks healthcare AI experience;
- you need to move faster than hiring allows;
- the work is temporary/project-based;
- you need product discovery as well as coding;
- the integration is unusually specialized;
- you want to validate before building a permanent team.
For startups, an external team can also bridge the period between idea and hiring a CTO/engineering organization.
The important thing is avoiding technical hostage situations. Repositories, infrastructure, documentation and IP should be arranged so the customer can take control when needed.
When no-code or ChatGPT is enough
Sometimes neither SaaS procurement nor custom development is necessary.
If five employees need to summarize non-sensitive internal text once a week, a general AI tool may solve the problem.
If a workflow is simple enough for Zapier/Make/Power Automate and the data/security requirements fit, use them.
If a spreadsheet fixes the problem, I am morally capable of recommending a spreadsheet.
The goal is not to maximize the amount of AI architecture.
The goal is to make the expensive problem disappear.
A decision table
| Question | Buy usually wins | Build usually wins |
|---|---|---|
| Workflow | Common/standard | Unique/proprietary |
| Integration | Vendor supports your stack | Deep/custom/legacy integration |
| Time to launch | Need it now | Can invest in product development |
| Control | Standard configuration is enough | Fine-grained behavior matters |
| IP | Not strategic | Core to company/product |
| Deployment | Standard cloud acceptable | On-prem/private/unusual requirements |
| Language/local rules | Well supported | Weakly supported or highly local |
| Change frequency | Vendor roadmap fits | You need to control roadmap |
Most projects are not entirely on one side.
That is why hybrid architecture is so common.
A quick test before you build
Before approving custom development, I would ask:
- Is there already a product that solves at least 80% of this?
- Is the missing 20% actually valuable enough to justify ownership?
- Can we integrate the existing product instead of replacing it?
- Are we building a reusable capability or a one-off workaround?
- Who will maintain it after launch?
- What evidence would prove the custom version creates enough value?
If the answer to #1 is yes and the missing 20% is mostly preference, buy.
If the missing 20% is your core workflow, integration or competitive advantage, build may make sense.
When AIn’t Doctor is the wrong choice
If you need a standard product that already exists and fits your workflow, I would rather point you at it than invoice you to rebuild it.
If you need one simple landing-page chatbot, there are cheaper vendors.
If your internal team already knows exactly how to build the system, you may need consulting or nothing from us at all.
We make the most sense when the project sits in the uncomfortable middle:
healthcare workflow + real systems + sensitive data + AI logic + integrations + enough edge cases that the standard product does not quite fit.
That territory is messier than SaaS.
It is also where custom work earns its keep.
Want to pressure-test build vs buy for one specific workflow?
See how our consulting/discovery works →